Varicella Virus Vaccine Live Market Insights Video
According to Cognitive Market Research, the global Varicella Virus Vaccine Live market size will be USD 3425.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 3.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1370.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1027.65 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 787.87 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 171.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 68.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.
The private category is experiencing the fastest growth rate in the Varicella Virus Vaccine Live industry
